Furosemide Injection 20mg 2ml COMPOSITION: Each Ampoule contains: Furosemide BP 20 mg THERAPEUTC INDICATIONS: Furosemide is a potent diuretic and is recommended for use when prompt and effective diuresis is required. Furosemide Injection BP 20mg/2ml and 50mg/5ml are appropriate for use in emergencies or where oral therapy is not feasible. The indications include cardiac, pulmonary, hepatic and renal oedema. Furosemide Injection BP 250mg/25ml is for use in the management of oliguria due to acute or chronic renal insufficiency with a glomerular filtration rate below 20ml/minute. DOSAGE AND DIRECTIONS FOR USE: Furosemide Injection BP 20mg/2ml and 50mg/5ml are for intramuscular or for intravenous administration and must always be given slowly. Furosemide Injection BP 250mg/25ml is for slow intravenous administration. FUROSEMIDE INJECTION BP 20MG/2ML AND 50MG/5ML: Adults: Initially, doses of 20-50mg may be administered by the intramuscular route, or by slow intravenous injection at a rate not exceeding 4mg/minute. The diuretic effect of furosemide is proportional to the dosage and, if larger doses are required, they should be given as a controlled infusion at a rate not exceeding 4mg/minute and titrated according to the response. Elderly: Elimination of furosemide is generally slower in the elderly. Dosage should be titrated until the required effect is achieved. Children: Dosages for children range from 0.5-1.5mg/kg weight daily up to a maximum total daily dose of 20mg. FUROSEMIDE INJECTION BP 250MG/25ML: Adults: Furosemide Injection BP 250mg/25ml is for slow intravenous injection at a rate not exceeding 4mg/minute. Elderly: Elimination of furosemide is generally slower in the elderly. Dosage should be titrated until the required effect is achieved. Children: Dosages for children must be determined on the basis of the severity of the renal insufficiency and on the clinical response to initial doses. SPECIAL WARNINGS AND PRECAUTIONS FOR USE: Urinary output must be secured. Patients with partial obstruction of urinary outflow, for example patients with prostatic hypertrophy or impairment of micturition have an increased risk of developing acute retention and require careful monitoring. Where indicated, steps should be taken to correct hypotension or hypovolaemia before commencing therapy. WARNING: Keep this medicine out of sight and reach of children. STORAGE: Store in the original package in order to protect from light and moisture. PRESENTATION: Box of 10 or 100 ampoules of 2ml VALIDITY: 3 years.
Audited Supplier 
){kind=link}